- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
PCMT1 as a prognostic marker in breast cancer ; day:5 ; month:9 ; year:2024 ; pages:1-11
Clinical and translational oncology ; (5.9.2024), 1-11
- Creator
-
Rogaczewski, Patryk
Janiak, Michał
Borowczak, Jędrzej
Szylberg, Łukasz
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12094-024-03695-y
- URN
-
urn:nbn:de:101:1-2411212203578.194745867842
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rogaczewski, Patryk
- Janiak, Michał
- Borowczak, Jędrzej
- Szylberg, Łukasz
- SpringerLink (Online service)
Other Objects (12)
Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
Glycoconjugates as prognostic markers in ovarian cancer
Glycoconjugates as prognostic markers in ovarian cancer
An assessment of prognostic immunity markers in breast cancer
Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment
Clinical impact of PTEN methylation status as a prognostic marker for breast cancer
RECK is not an independent prognostic marker for breast cancer
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance
SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy
Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
Glycoconjugates as prognostic markers in ovarian cancer
Glycoconjugates as prognostic markers in ovarian cancer
An assessment of prognostic immunity markers in breast cancer
Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment
Clinical impact of PTEN methylation status as a prognostic marker for breast cancer
RECK is not an independent prognostic marker for breast cancer
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance
SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy
Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
Glycoconjugates as prognostic markers in ovarian cancer
Glycoconjugates as prognostic markers in ovarian cancer
An assessment of prognostic immunity markers in breast cancer
Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment
Clinical impact of PTEN methylation status as a prognostic marker for breast cancer
RECK is not an independent prognostic marker for breast cancer
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance
SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells